BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 15243526)

  • 1. Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases.
    Chen YF; Yang PY; Hu DN; Kuo FS; Hung CS; Hung CM
    J Am Acad Dermatol; 2004 Jul; 51(1):68-74. PubMed ID: 15243526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation of autologous minigrafts for the treatment of stable vitiligo.
    Sun X; Qian G; Wu Y; Shen H; Wang T; Hu J; Guo B; Wu J; Xu A
    J Dermatolog Treat; 2012 Apr; 23(2):122-7. PubMed ID: 21254850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable vitiligo treated by a combination of low-dose oral pulse betamethasone and autologous, noncultured melanocyte-keratinocyte cell transplantation.
    Mulekar SV
    Dermatol Surg; 2006 Apr; 32(4):536-41. PubMed ID: 16681662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous noncultured melanocyte transplantation for stable vitiligo: can suspending autologous melanocytes in the patients' own serum improve repigmentation and patient satisfaction?
    Sahni K; Parsad D; Kanwar AJ; Mehta SD
    Dermatol Surg; 2011 Feb; 37(2):176-82. PubMed ID: 21269348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ratio of size of recipient and donor areas in treatment of vitiligo by autologous cultured melanocyte transplantation.
    Hong WS; Hu DN; Qian GP; McCormick SA; Xu AE
    Br J Dermatol; 2011 Sep; 165(3):520-5. PubMed ID: 21564070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up study of 142 patients with vitiligo vulgaris treated by autologous, non-cultured melanocyte-keratinocyte cell transplantation.
    Mulekar SV
    Int J Dermatol; 2005 Oct; 44(10):841-5. PubMed ID: 16207186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation.
    Mulekar SV
    Arch Dermatol; 2004 Oct; 140(10):1211-5. PubMed ID: 15492183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous melanocyte-keratinocyte suspension in the treatment of vitiligo.
    El-Zawahry BM; Zaki NS; Bassiouny DA; Sobhi RM; Zaghloul A; Khorshied MM; Gouda HM
    J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):215-20. PubMed ID: 20569286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanocyte transplantation for the treatment of vitiligo: effects of different surgical techniques.
    Issa CM; Rehder J; Taube MB
    Eur J Dermatol; 2003; 13(1):34-9. PubMed ID: 12609779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of melanocytes transplantation methods for the treatment of vitiligo.
    Czajkowski R
    Dermatol Surg; 2004 Nov; 30(11):1400-5. PubMed ID: 15522021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of autologous transplantation of noncultured epidermal suspension in two different dilutions in the treatment of vitiligo.
    Tegta GR; Parsad D; Majumdar S; Kumar B
    Int J Dermatol; 2006 Feb; 45(2):106-10. PubMed ID: 16445497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-cultured melanocyte-keratinocyte transplantation for the treatment of vitiligo: a clinical trial in an Iranian population.
    Toossi P; Shahidi-Dadras M; Mahmoudi Rad M; Fesharaki RJ
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1182-6. PubMed ID: 21214632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repigmentation in vitiligo patients. Melanocyte transfer via ultra-thin grafts.
    Kahn AM; Cohen MJ
    Dermatol Surg; 1998 Mar; 24(3):365-7. PubMed ID: 9537012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncultured epidermal suspension transplantation for the treatment of stable vitiligo in children and adolescents.
    Sahni K; Parsad D; Kanwar AJ
    Clin Exp Dermatol; 2011 Aug; 36(6):607-12. PubMed ID: 21507039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo.
    van Geel N; Ongenae K; De Mil M; Haeghen YV; Vervaet C; Naeyaert JM
    Arch Dermatol; 2004 Oct; 140(10):1203-8. PubMed ID: 15492182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanocyte-keratinocyte transplantation procedure in the treatment of vitiligo: the experience of an academic medical center in the United States.
    Huggins RH; Henderson MD; Mulekar SV; Ozog DM; Kerr HA; Jabobsen G; Lim HW; Hamzavi IH
    J Am Acad Dermatol; 2012 May; 66(5):785-93. PubMed ID: 21864935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous melanocyte transfer via epidermal grafts for lip vitiligo.
    Gupta S; Goel A; Kanwar AJ; Kumar B
    Int J Dermatol; 2006 Jun; 45(6):747-50. PubMed ID: 16796641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous cultured melanocytes in vitiligo treatment.
    Czajkowski R; Placek W; Drewa T; Kowaliszyn B; Sir J; Weiss W
    Dermatol Surg; 2007 Sep; 33(9):1027-36; discussion 1035-6. PubMed ID: 17760593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing melanocyte cultures in a serum-free system for transplantation in vitiligo patients.
    Czajkowski R; Placek W; Drewa T; Olszewska-SÅ‚onina D; Sir J; Kowaliszyn B; Weiss M
    Med Sci Monit; 2006 Feb; 12(2):CR63-9. PubMed ID: 16449949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of excimer laser (308 nm) for vitiligo at different body sites.
    Hofer A; Hassan AS; Legat FJ; Kerl H; Wolf P
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):558-64. PubMed ID: 16684284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.